Abstract
Purpose
To report the clinical manifestation, predisposing factors, microbiological profiles and treatment outcome of infectious keratitis following penetrating keratoplasty (PK).
Methods
Medical records of the post-PK patients later diagnosed with culture-positive keratitis, between January 2003 and June 2008 at our hospital were retrospectively reviewed.
Results
Among 228 eyes of 226 patients who previously had PK, 18 eyes (7.89%) of 16 patients developed microbial keratitis. Fifteen patients had a bacterial infection, of which a Streprococcus species was the most common causative microorganism (6 eyes, 33.3%). Three eyes had fungal infection; one case was co-infected with bacteria. Six eyes (33.3%) presented with a suture-related problem, and sixteen eyes (88.9%) had been using topical glaucoma medications. The suture-related problem and use of glaucoma medication were significantly associated with the development of infectious keratitis (p=0.040 and 0.013, respectively). Remission was achieved in all cases within the mean duration of 2.47 months after treatment initiation. However, visual improvement was not achieved in 11 eyes (68.7%) due to graft opacity.
References
1. Vajpayee RB, Boral SK, Dada T, et al. Risk factors for graft abdominal in India: a case-controlled study. Br J Ophthalmol. 2002; 86:261–5.
2. Al-Hazzaa SA, Tabbara KF. Bacterial keratitis after penetrating keratoplasty. Ophthalmology. 1988; 95:1504–8.
3. Bates AK, Kirkness CM, Ficker LA, et al. Microbial keratitis after penetrating keratoplasty. Eye. 1990; 4:74–8.
4. Wagoner MD, Al-Swailem SA, Sutphin JE, Zimmerman MB. Bacterial Keratitis after Penetrating Keratoplasty Incidence, Microbiological Profile, Graft Survival, and Visual Outcome. Ophthalmology. 2007; 114:1073–9.
5. Tixier J, Bourcier T, Borderie V, et al. Infectious keratitis after penetrating keratoplasty. J Fr Ophtalmol. 2001; 24:597–602.
6. Ha DW, Kim CK, Lee SE, et al. Penetrating keratoplasty results in 275 Cases. J Korean Ophthalmol Soc. 2001; 42:20–9.
7. Lee SJ, Cho EY, Kim MS. Clinical Outcomes 10 Years after Penetrating Keratoplasty. J Korean Ophthalmol Soc. 2006; 47:1043–8.
8. Choi SH, Lee YW, Kim HM, et al. Epidemiologic Studies of Keratoplasty in Korea. J Korean Ophthalmol Soc. 2006; 47:538–47.
9. Das S, Constantinou M, Ong T, Taylor HR. Microbial keratitis following corneal transplantation. Clin Experiment Ophthalmol. 2007; 35:427–31.
10. Akova YA, Onat M, Koc F, et al. Microbial keratitis following penetrating keratoplasty. Ophthalmic Surg Lasers. 1999; 30:449–55.
11. Rahman I, Carley F, Hillarby C, et al. Penetrating keratoplasty: indications, outcomes, and complications. Eye. 2009; 23:1288–94.
12. Siganos CS, Solomon A, Frucht-Pery J. Microbial findings in abdominal erosion after penetrating keratoplasty. Ophthalmology. 1997; 104:513–6.
13. Harris DJ, Stulting RD, Waring GO 3rd, Wilson LA. Late abdominal and fungal keratitis after corneal transplantation. Spectrum of pathogens, graft survival, and visual prognosis. Ophthalmology. 1988; 95:1450–7.
14. Gopinathan U, Sharma S, Garg P, Rao GN. Review of abdominal features, microbiological diagnosis and treatment outcome of microbial keratitis: Experience of over a decade. Indian J Ophthalmol. 2009; 57:273–9.
15. Yeh DL, Stinnett SS, Afshari NA. Analysis of bacterial cultures in infectious keratitis, 1997 to 2004. Am J Ophthalmol. 2006; 142:1066–8.
16. Bharathi MJ, Ramakrishnan R, Meenakshi R, et al. Microbiological diagnosis of infective keratitis: comparative evaluation of abdominal microscopy and culture results. Br J Ophthalmol. 2006; 90:1271–6.
17. Fong LP, Ormerod LD, Kenyon KR, Foster CS. Microbial abdominal complicating penetrating keratoplasty. Ophthalmology. 1998; 95:1269–75.
Table 1.
No | Age | Sex | Indications for corneal graft | Laterality | Isolated organism | Months to infection |
---|---|---|---|---|---|---|
1 | 74 | M | PBK | OS | Streptococcus pneumoniae | 3 |
2 | 75 | F | PBK | OS | Pseudomonas putida | 13 |
3* | 63 | F | Herpes simplex keratitis | OD | Coagulase negative Staphylococcus | 0.33 |
3* | Pseudomonas fluorescens/putida | 39 | ||||
4 | 69 | F | PBK | OS | Acremonium species, Corynebacterium species | 20 |
5 | 71 | F | Herpes simplex keratitis | OD | Methicillin Resistant Staphylococcus Epidermidis | 10 |
6 | 34 | M | Exposure keratopathy | OS | Streptococcus pneumoniae | 9 |
7* | 48 | M | Traumatic corneal laceration | OS | Streptococcus mitis | 11 |
7* | Bacterial keratitis | OS | Acinetobacter baumannii, Acinetobacter lwoffii | 2 | ||
8 | 51 | M | Chemical burn | OD | Delftia(Comamonas) acidovorans | 15 |
9 | 73 | M | Herpes simplex keratitis | OS | Serratia marcescens | 7 |
10 | 72 | M | PBK | OS | Granulicatella adiacens | 24 |
11 | 63 | M | ABK | OS | Candida albicans | 26 |
12 | 69 | F | PBK | OD | Streptococcus, Corynebacterium | 4 |
13 | 59 | M | Salzmann's nodular degeneration | OS | Streptococcus pneumoniae | 21 |
14 | 8 | M | Corneal opacity, S/P Shield ulcer | OS | Streptococcus pneumoniae | 4 |
15 | 64 | F | Corneal opacity with unknown cau | use OD | Fusarium species | 37 |
16 | 39 | M | Corneal opacity with unknown cau | use OS | Staphylococcus aureus | 16 |
Table 2.
Table 3.
Infectious keratitis (+) | Infectious keratitis (−) | P-value | |
---|---|---|---|
No | 18 eyes | 210 eyes | |
Sex (M:F) | 11 (61%):7 (38.9%) | 131 (62.4%):79 (37.6%) | 1.0 |
Age (yrs) | 58.2±4.59 | 50.3±1.26 | 0.096 |
Laterality (OD:OS) | 6 (33.3%):12 (66.7%) | 101 (48.1%):109 (51.9%) | 0.325 |
Diabetes mellitus | 5 eyes (27.7%) | 22 eyes (10.9%) | 0.128 |
Previous history of graft rejection | 5 eyes (27.7%) | 67 eyes (31.9%) | 0.798 |
Duration of topical steroid use | 18.1 months | 23.5 months | 0.177 |
Suture-related problem* | 6 eyes (33.3%) | 31 eyes (14.8%) | 0.04 |
Use of glaucoma eyedrops* | 15 eyes (83.0%) | 80 eyes (42.8%) | 0.013 |